Screener
Jazz Pharmaceuticals JAZZ Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $1,844.3 | $1,391.9 |
| Investments | 1,030.0 | 1,050.0 |
| Accounts receivable, net of allowances | 836.3 | 830.7 |
| Inventories | 437.5 | 417.0 |
| Prepaid expenses | 149.7 | 152.5 |
| Other current assets | 285.3 | 323.9 |
| Total current assets | 4,583.1 | 4,166.0 |
| Property, plant and equipment, net | 203.1 | 199.9 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's inventories?
- Jazz Pharmaceuticals (JAZZ) reported inventories of $437.5M in Q1 2026.
- How has Jazz Pharmaceuticals's inventories changed year-over-year?
- Jazz Pharmaceuticals's inventories decreased by 11.2% year-over-year, from $492.78M to $437.5M.
- What is the long-term trend for Jazz Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's inventories has grown at a 34.3% compound annual growth rate (CAGR), from $95.4M to $417M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Jazz Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude